Woodford Equity Income

takesyourchances

ColdIron wrote: »

CTY gets my vote

That is my gut feeling CTY for this money with Woodford's fund, I have set to sell out of Woodford and when the £3500 odd is cleared will move these funds into my CTY holding which is more suited for this income portfolio. It is a decision I needed to make with Woodfords not being what it set out to be at launch.

takesyourchances

That is my previous Woodford funds sold today and I placed the £3500 odd into my CTY so that's all taken care of and all in City of London now for my long term holding for this part of my portfolio.



.

Wildsound

For UK Equity Income, I would go with one (or more) of the following in the OEIC universe:

Threadneedle UK Equity Income
LF Miton UK Multi Cap Income (my personal choice, better than average long term performance and lower than average volatility)
Franklin UK Equity Income

takesyourchances

Wildsound wrote: »

For UK Equity Income, I would go with one (or more) of the following in the OEIC universe:

Threadneedle UK Equity Income
LF Miton UK Multi Cap Income (my personal choice, better than average long term performance and lower than average volatility)
Franklin UK Equity Income

I also hold Marlborough Multi Cap Income for several years and CTY. Woodford never turned out what it set out to at launch with dividend percentage and performance and a high amount of unquoted holdings which I don't want.



I have sorted that section out now and felt Woodfords no longer had a place as I opened it for UK Equity Income from the start but it veered off.

aroominyork

I just looked at Woodford's website and the 'opportunities' section for Patient Capital. It kind of suggests the purpose of the IT is to act as an angel: "A long-term 'patient capital' approach can deliver extremely successful outcomes and help businesses fulfil their potential, while also helping to develop the UK's 'knowledge economy' and support the much-needed economic rebalancing." I guess that's one way of defending its horrendous performance.

Thrugelmir

aroominyork wrote: »

I guess that's one way of defending its horrendous performance.

Against the wall of money that's being invested in index trackers creating a self fulfilling prophecy. Investing in start-ups has no chance. As simply not as exciting. Though longer term may be far more rewarding. Depending upon one's investment horizon of course. Fund isn't called patient for no reason.

Voyager2002

Thrugelmir wrote: »

Against the wall of money that's being invested in index trackers creating a self fulfilling prophecy. Investing in start-ups has no chance. As simply not as exciting. Though longer term may be far more rewarding. Depending upon one's investment horizon of course. Fund isn't called patient for no reason.

Incidentally, are you aware of any reason why the price of Patient Capital recovered at the end of the week?

Alexland

Voyager2002 wrote: »

Incidentally, are you aware of any reason why the price of Patient Capital recovered at the end of the week?

Maybe a rumour they were changing the manager?

ColdIron

Voyager2002 wrote: »

Incidentally, are you aware of any reason why the price of Patient Capital recovered at the end of the week?

Syncona (SYNC) and Woodford Patient Capital (WPCT) – the best and worst performing investment trusts focused on life sciences – joined the leaders in a stock market rally today, as Autolus, a cancer specialist in which they both own stakes, priced its US flotation at the top end of expectations.

http://citywire.co.uk/wealth-manager/news/ftse-rallies-as-syncona-and-woodford-bask-in-autolus-glow/a1131847

bundoran

Voyager2002 wrote: »

Incidentally, are you aware of any reason why the price of Patient Capital recovered at the end of the week?

Maybe a dead cat bounce?